Compare · CBOE vs ROBO
CBOE vs ROBO
Side-by-side comparison of Cboe Global Markets, Inc. (CBOE) and Exchange Traded Concepts Trust ROBO Global Robotics and Automa (ROBO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBOE and ROBO operate in n/a (n/a), so they compete in similar markets.
- CBOE carries a market cap of $13.01B.
- Over the past year, CBOE is up 25.5% and ROBO is up 29.3% - ROBO leads by 3.8 points.
- CBOE has hit the wire 6 times in the past 4 weeks while ROBO has been quiet.
- CBOE has more recent analyst coverage (25 ratings vs 0 for ROBO).
Cboe Global Markets, Inc.
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, European Equities, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities; and offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The European Equities segment offers pan-European listed equities transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
Exchange Traded Concepts Trust ROBO Global Robotics and Automa
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global® Robotics and Automation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of robotics-related and/or automation-related companies. The fund may invest up to 20% of its assets in investments that are not included in the index, but which the Adviser and Sub-Adviser believe will help it track the index. It is non-diversified.
Latest CBOE
- SEC Form 10-Q filed by Cboe Global Markets, Inc.
- Cboe Global Markets Reports Results for Second Quarter 2026
- Cboe Global Markets, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Cboe Global Markets, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Cboe Global Markets Announces Date of Second-Quarter 2026 Earnings Release and Conference Call
- Cboe Global Markets Reports Trading Volume for June 2026
- Director Tomczyk Fredric J covered exercise/tax liability with 337 shares, decreasing direct ownership by 0.94% to 35,631 units (SEC Form 4) (withholding tax)
- Cboe Global Markets, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Cboe Introduces Cboe Predicts, Launching First Products in New Prediction Markets Suite
- Cboe Global Markets downgraded by Erste Group
Latest ROBO
- Meet the Future at Exchange as ETC Introduces the Wealth and Asset Management World to Tangible, Talking Example of Today's Emerging Economic Engines
- AI Surge Sparks Fears Of Dot-Com-Like Bubble Burst
- Nvidia's Top Customer May Be Microsoft, Accounting For A Fifth Of Its Revenue: Report
- Artificial Intelligence ETFs: Have They Beaten The Market In 2024?
- Microsoft, Alphabet And Meta's Raised AI Capex Outlook Could Benefit These JPMorgan Stock Picks
- Elon Musk-Backed Brain Chip Implant Neuralink Under Scrutiny Lens Following FDA's Oversight Regulatory Compliance
- Elon Musk-Backed Neuralink's Animal Studies Have Red Flags, FDA Uncovers Deficiencies
- 3 Global Robotics Stocks To Consider As Market Grows At Annual Rate Of 14.7%
- Artificial Intelligence ETF Holders Are 37% Richer: But Regulators See 'Emerging Threat' To Stability
- How Education, Student Loan Repayment And Research Suffers If Government Shuts Down